Literature DB >> 27882218

Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12.

Zhi Guo1, Hong-Yan Gao1, Tian-Yang Zhang1, Jin-Xing Lou1, Kai Yang1, Xiao-Dong Liu1, Xue-Peng He1, Hui-Ren Chen1.   

Abstract

The aim of the present study was to construct a chimeric adenovirus (Ad)5/F35 co-expressing human CD4O ligand (CD4OL) and interleukin (IL)-2 (Ad5/F35 CD40L-IL-2). The infection efficiency to human monocyte-derived dendritic cells (Mo-DCs), expression of genes, phenotype changes and IL-12 production of Mo-DC by Ad5/F35 CD40L-IL-2 were investigated. CD40L and IL-2 from total RNA extracted from human peripheral blood mononuclear cells (PBMCs) were cloned by reverse transcription-polymerase chain reaction and used to construct Ad5/F35 CD40L-IL-2. The infection efficiency, expression of CD40L, and phenotype changes of Mo-DC infected with Ad5/F35 CD40L-IL-2 were analyzed using flow cytometry. The quantities of IL-2 and IL-12 in the supernatants of Mo-DC following infection of Ad5/F35 CD40L-IL-2 were measured by enzyme-linked immunosorbent assay. The CD40L and IL-2 genes were successfully cloned and the Ad5/F35 CD40L-IL-2 was constructed. Ad5/F35 CD40L-IL-2 efficiently infected Mo-DCs with an infection efficiency of >75%, and the infected Mo-DCs expressed CD40L and secreted IL-2. The expression levels of cluster of differentiation (CD)80, CD86, CD40, and human leukocyte antigen-antigen D related on Mo-DC were moderate; however, CD83 was low prior to infection of Ad5/F35 CD40L-IL-2. Those molecules, particularly CD83, were markedly upregulated 24 h after the infection. Increasing quantities of IL-12 in the supernatants were detected subsequent to infection at different time points in a time-dependent manner. Thus, Ad5/F35 CD40L-IL-2 efficiently infected human Mo-DCs and its products, CD40L and IL-2, were subsequently expressed. In addition, infection with Ad5/F35 CD40L-IL-2 stimulated the maturation of Mo-DC and high levels of IL-12 production.

Entities:  

Keywords:  CD40 ligand; chimeric adenovirus 5/F35; dendritic cells; interleukin-12; interleukin-2

Year:  2016        PMID: 27882218      PMCID: PMC5103675          DOI: 10.3892/br.2016.773

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  30 in total

1.  Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector.

Authors:  Michael Andrew Balamotis; Katie Huang; Kohnosuke Mitani
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

2.  Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.

Authors:  M Kelleher; P C Beverley
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2).

Authors:  Xiaofang Hu; Yan Cao; Yiming Meng; Mingxiao Hou
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.

Authors:  Miriam E Mossoba; Jeffrey A Medin
Journal:  Expert Rev Vaccines       Date:  2006-10       Impact factor: 5.217

5.  Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

Authors:  Raphaël F Rousseau; Ettore Biagi; Aurélie Dutour; Eric S Yvon; Michael P Brown; Tiffany Lin; Zhuyong Mei; Bambi Grilley; Edwina Popek; Helen E Heslop; Adrian P Gee; Robert A Krance; Uday Popat; George Carrum; Judith F Margolin; Malcolm K Brenner
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

Review 6.  Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity.

Authors:  R Kim; M Emi; K Tanabe
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo.

Authors:  Yanping Cun; Qinhong Zhang; Chengjie Xiong; Mengxia Li; Nan Dai; Shiheng Zhang; Dong Wang
Journal:  Oncol Rep       Date:  2013-04-04       Impact factor: 3.906

Review 8.  Exploiting internal ribosome entry sites in gene therapy vector design.

Authors:  S M Ngoi; A C Chien; C G L Lee
Journal:  Curr Gene Ther       Date:  2004-03       Impact factor: 4.391

9.  Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.

Authors:  Benita Wolf; Adrian Schwarzer; Anik L Côté; Thomas H Hampton; Thomas Schwaab; Eduardo Huarte; Craig R Tomlinson; Jiang Gui; Jan L Fisher; Camilo E Fadul; Joshua W Hamilton; Marc S Ernstoff
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

10.  Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.

Authors:  Irina Y Tcherepanova; Melissa D Adams; Xiaorong Feng; Atsushi Hinohara; Joe Horvatinovich; David Calderhead; Don Healey; Charles A Nicolette
Journal:  BMC Mol Biol       Date:  2008-10-17       Impact factor: 2.946

View more
  1 in total

1.  Cluster analysis of splenocyte microRNAs in the pig reveals key signal regulators of immunomodulation in the host during acute and chronic Toxoplasma gondii infection.

Authors:  Zhaofeng Hou; Hui Zhang; Kangzhi Xu; Shifan Zhu; Lele Wang; Dingzeyang Su; Jiantao Liu; Shijie Su; Dandan Liu; Siyang Huang; Jinjun Xu; Zhiming Pan; Jianping Tao
Journal:  Parasit Vectors       Date:  2022-02-17       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.